Cas:142893-66-1 2-(2,6-dimethylmorpholin-4-yl)acetic acid,hydrochloride manufacturer & supplier

Chemical Name:2-(2,6-dimethylmorpholin-4-yl)acetic acid,hydrochloride

CAS.NO:142893-66-1

Synonyms:2-(2,6-dimethylmorpholin-4-yl)acetic acid,hydrochloride

Molecular Formula:C₈H₁₅NO₃

Molecular Weight:173.21000

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:279.2ºC at 760 mmHg

Density:1.077g/cm3

Index of Refraction:1.458

PSA:49.77000

Exact Mass:173.10500

LogP:0.11810

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(2,6-dimethylmorpholin-4-yl)acetic acid,hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2,6-dimethylmorpholin-4-yl)acetic acid,hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2,6-dimethylmorpholin-4-yl)acetic acid,hydrochloride Use and application,2-(2,6-dimethylmorpholin-4-yl)acetic acid,hydrochloride technical grade,usp/ep/jp grade.

Related News: CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. Fats and Glyceridic oils, menhaden, polymers with ethylene glycol, maleic anhydride, pentaerythritol and phthalic anhydride manufacturers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 1-acetyl-4,4-bis-(4-chloro-phenyl)-1,4-dihydro-2H-cinnolin-3-one suppliers Stevanato’s been out of start-up mode for a while: The firm doubled its net profit to $94 million in 2020 on $779 million in revenues, which were up 23% from 2019. That strong growth in sales helped place Sergio Stevanato, 79, Giovanni’s son and the company’s chairman emeritus, on Forbes’ World’s Billionaires list for the first time in 2021, with a net worth of $1.9 billion. Peptide,(Xaa-Gly-Phe-Ser-Phe-Ser-Val-Trp-Ala-Met-Ser-Xaa-Tyr-Ile-Ser-Arg-Thr-Ser-Lys-Thr-Ile-Tyr-Tyr-Ala-Asp-Ser-Val-Lys-Gly-Xaa-Ala-Arg-Gly-Arg-Phe-Phe-Asp-Tyr) vendor & factory CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. ,Stevanato’s been out of start-up mode for a while: The firm doubled its net profit to $94 million in 2020 on $779 million in revenues, which were up 23% from 2019. That strong growth in sales helped place Sergio Stevanato, 79, Giovanni’s son and the company’s chairman emeritus, on Forbes’ World’s Billionaires list for the first time in 2021, with a net worth of $1.9 billion.